Keywords: bolus i.v. injection, inulin clearance, kinetic analysis

Size: px
Start display at page:

Download "Keywords: bolus i.v. injection, inulin clearance, kinetic analysis"

Transcription

1 Br J Clin Pharmacol 1998; 46: Determination of inulin clearance by bolus intravenous injection in healthy subjects and ascitic patients: equivalence of systemic and renal clearances as glomerular filtration markers R. Orlando, 1 M. Floreani, 2 R. Padrini 2 & P. Palatini 2 1 Institute of Clinical Medicine and 2 Department of Pharmacology, University of Padova, Italy Aims Determination of systemic inulin clearance by the standard technique of constant intravenous infusion has long been accepted as a reliable method for measuring glomerular filtration rate (GFR) without urine collection, except in oedematous patients. However, recent studies using standard clearance techniques have claimed that systemic inulin clearance is significantly greater than renal clearance and therefore overestimates GFR. The main purpose of this investigation was to re-evaluate the relationship between systemic and renal inulin clearance using a different technical approach. A reassessment was also made of inulin disposition kinetics. Methods Systemic and renal inulin clearances were simultaneously evaluated, in healthy subjects and patients with oedema and ascites, by analysis of the total area under the plasma concentration-time curve (AUC) following bolus intravenous injection. Renal clearance was calculated as the ratio of the total amount recovered in the urine to the AUC, and systemic clearance as dose/auc. Results Inulin disposition kinetics were best described by a tri-exponential model. In healthy subjects the volume of the central compartment (mean (s.d.) value 3.86 (1.00) 70 kg 1 ) was slightly greater than the plasma volume; steady-state volume of distribution was (1.21) l 70 kg 1, in accordance with the tenet that the inulin space is somewhat smaller than the extracellular fluid volume. The values of systemic and renal inulin clearances were very similar (96.1 (10.0) and 94.6 (12.5) ml min 1 70 kg 1, respectively, in healthy subjects; (16.3) and (18.5) ml min 1 in ascitic patients). They were also highly correlated to each other in both healthy subjects (r=0.96, P<0.001) and patients with ascites (r=0.98, P<0.001). Conclusions The method described here constitutes a simpler and more precise technique for measuring renal inulin clearance than the standard method, which is based on constant infusion and timed collections of urine samples, since it avoids errors connected with short successive urine collections. By the present method we demonstrated that renal and systemic inulin clearances are virtually identical in both healthy subjects and patients with expanded extracellular fluid volume. Determination of systemic inulin clearance by the presently described technique is therefore a method of general validity for measuring GFR without urine collection. Keywords: bolus i.v. injection, inulin clearance, kinetic analysis Introduction is eliminated exclusively by renal excretion, Earle and coworkers [2, 3] proposed to determine systemic inulin Measurement of glomerular filtration rate (GFR) is necessary clearance in place of renal clearance. This technique, which in both clinical practice and research fields for assessing renal obviates the need for urine collection, has since been shown function. The renal clearance of inulin is accepted as one of to be a valid and convenient substitute for measurement of the reference standards for GFR estimation [1]. The classical renal clearance, except in patients with expanded extracellular method for determination of inulin clearance, which requires fluid volume because of oedema and/or ascites [1, 3]. This constant intravenous infusion and timed collections of urine practice has been questioned by three recent studies [4 6], samples, is impractical and particularly inconvenient for which found systemic inulin clearance values significantly patients. Therefore, alternative clearance techniques have higher (up to 20%) than those of renal clearance. According been developed. Since there is general consensus that inulin to van Acker et al. [6] this was attributable to extrarenal clearance or to storage in a compartment that is characterized Correspondence: Professor Pietro Palatini, Dipartimento di Farmacologia, Università by slow diffusion. In these studies, renal clearance was di Padova, Largo E. Meneghetti 2, Padova, Italy. measured by means of the classic UV/P method, i.e. from 1998 Blackwell Science Ltd 605

2 R. Orlando et al. the ratio of renal excretion rate to plasma inulin concentration, rate over 1 min by a precise volumetric infusion pump. following either constant intravenous (i.v.) infusion [4, 6] or Inulin vials used throughout the study were from the same bolus i.v. ( single-shot ) injection [5]. However, with either batch. Blood samples (4 ml) were taken from a cannula administration technique, this method has technical drawbacks. placed in an antecubital vein of the opposite arm at 0 If it is based on short, successive urine collections, ( predosing), 2, 5, 10, 15, 20, 30, 45, 60, 90, 120, 150, 180, variations in the completeness of bladder emptying produce 210 and 240 min after the end of the infusion. Blood was substantial errors in the evaluation of the renal excretion rate drawn into heparinized plastic tubes and centrifuged immediately. [1]. Bladder catheterization, that would ensure more precise Plasma samples were stored at 40 C until assayed. determinations of the excretion rate, may cause bladder Urine was collected before and from 0 4 and 4 12 h after infections and is not considered acceptable in volunteers. If dosing. Serial determinations in the urine of the first four observations are performed over an extended period of time, subjects (two healthy subjects and two ascitic patients) had wide fluctuations (up to 50%) may occur in plasma inulin shown that inulin was no longer detectable or present in concentration, probably due to the circadian rhythm of renal traces after 12 h. Mean urinary recovery was 98 [5]% of the function [6]. Therefore, the customary determination of a injected dose. Before starting the determination of inulin single plasma concentration at the mid-point of the urine clearance, all subjects received oral hydration with collection period may either grossly overestimate or underestimate 10 ml kg 1 of tap water. To maintain diuresis, urinary losses the average plasma concentration. The UV/P method were replaced by equal amounts of water. afterbolusi.v.injectionhasrecentlybeenshowntoprovide a poor estimate of inulin clearance [7]. The main aim of this study was to compare systemic and Assay method renal inulin clearances in healthy subjects and patients with Inulin in plasma and urine was determined by means of the ascites. Accordingly, both clearance parameters were deteranthrone method, after removal of glucose, essentially as mined by the area method [8], after bolus i.v. injection. described by Jung et al. [10]. Briefly, 0.3 ml of plasma or The disposition kinetics of inulin was also reassessed, since urine, appropriately diluted, were mixed with 0.05 ml of discrepant results regarding the distribution characteristics of the glucose-removing reagent (300 IU of glucose oxidase inulin have been obtained by two recent studies [7, 9]. (Sigma, St Louis, MO, USA) and IU of catalase (Boehringer, Mannheim, FRG) in 1 ml of 100 mm Methods triethanolamine-hcl buffer, ph 7.0) and incubated at 37 C for 4 h. Control experiments showed that the Subjects addition of glucose up to 10 mm (about twice the physiological concentration) to inulin samples had no effect Sixteen healthy male volunteers (mean (s.d.) age 54 (7) years, on the determinations. After incubation was completed, weight 73 (8) kg, height 170 (6) (cm) and eight male patients 0.35 ml of 10% trichloroacetic acid were added and the with decompensated liver cirrhosis (mean (s.d.) age 50 (7) mixture centrifuged at g for 10 min. One ml of years, weight 77 (10) kg, height 173 (5) cm) gave their 5.15 mm anthrone (Sigma) in sulphuric acid was then informed written consent to participate in this study, which added to 0.4 ml of supernatant and the mixture incubated was approved by the local Ethics Committee. Healthy subjects at 37 C for 60 min. All samples were run in duplicate. were recruited from outpatients attending the hospital for Absorbance was read at 623 nm. For each assay, inulin routine laboratory tests. Criteria for their selection were that concentration was calculated from a calibration curve they did not require any regular medication and had no obtained by dissolving inulin in water. Preliminary history of allergy to drugs. They were diagnosed as being experiments had shown that identical calibration curves healthy by means of a thorough clinical examination, were obtained if inulin was dissolved in plasma or urine. including medical history, physical examination and standard The assay was linear (r 2 >0.99) up to 250 mg l 1. The clinical laboratory tests. All cirrhotic patients had ascites and detection limit in plasma and urine was 2 mg l 1. The oedema of the lower extremities, and could be categorized as intra- and inter-assay coefficients of variation (n=10), Child s class C. Apart from the biochemical indices of liver determined at 20 and 200 mg l 1, were below 7 and 5%, function, all patients had normal laboratory test values, respectively. including glycaemia. Patients were excluded from this study if they had a recent history of gastrointestinal bleeding, severe encephalopathy or refractory ascites. Creatinine clearance of healthy subjects and patients ranged from and Pharmacokinetic analysis ml min 1, respectively. During the period of investi- The data were modelled by using the GraphPad Prism 2.0 gation all participants abstained from alcohol and tobacco and software. The inulin decay curve of each subject was took no drugs, apart from those used for the treatment of analysed by using a bi- or a tri-exponential equation. Initial cirrhosis (spironolactone or canrenone and vitamin estimates of the coefficients and exponents of the equations supplements). were obtained by a numerical technique. These estimates were then refined by iterative nonlinear regression analysis Protocol with a weighting factor of 1/C 2. Comparison between At h, after an overnight fast, 5 g of inulin (Inutest R, Laevosan GmHB, Linz, Austria) were infused at a constant competing models was made by means of the F-test. The total area under the plasma concentration-time curve (AUC) was calculated from the coefficients and exponents Blackwell Science Ltd Br J Clin Pharmacol, 46,

3 Short report Table 1 Mean (s.d.) pharmacokinetic parameters of inulin. Values of clearance and distribution volumes are normalized to 70 kg of body weight. V C V SS t 1/2 CL R CL CL R /CL% ( l) ( l) (h) (ml min 1 ) (ml min 1 ) (95%CI) Healthy subjects Mean a 98.5 (s.d.) (1.00) (1.21) (0.13) (12.5) (10.0) ( ) Ascitic patients Mean b 98.1 (s.d.) (1.21) (1.39) (0.23) (18.5) (16.3) ( ) P-value <0.02 <0.005 NS NS NS (healthy vs ascitic subjects) V C, apparent volume of the central compartment; V SS, apparent volume of distribution at steady-state; t 1/2, elimination half-life; CL R, renal clearance (calculated as Ae (2)/AUC); CL, systemic clearance. a P=0.48 and b P=0.26 vs CL R. of the equation which better fitted the data. Renal clearance (CL R ) was then calculated either as Ae (2)/AUC, i.e. from the ratio of the total amount recovered in the urine to total AUC, or as Ae (0 4)/AUC (0 4), (that is from the ratio of the amount excreted during the first 4 h to the corresponding AUC). Systemic clearance was calculated as dose/auc. Systemic clearance was also obtained from a limited number of data points (at 2, 15, 30, 60, 120 and 240 min) using the logarithmic trapezoidal rule with extrapolation to infinity. The other pharmacokinetic parameters, defined in Table 1, were calculated from standard equations [11]. Statistical analysis Plasma concentration (mgl 1 ) Time (min) A power analysis (CSS power assessment procedure; CSS,Statsoft Inc, Tulsa OK, USA, 1991) based on the coefficients of variation obtained by Buclin et al. [7] for renal clearance of inulin indicated that the sample sizes used in this study should be sufficient to detect differences of 10%, with a significance level (a) of 0.05 and a power (1- b) of Intragroup differences in inulin clearances were evaluated by means of Student s two-tailed paired t-test, whereas Student s nonpaired t-test was used for comparison of pharmacokinetic parameters between different study groups. Correlations were examined by linear regression analysis. Probability values <0.05 were considered statisti- cally significant. Figure 1 Plasma decay curves of inulin in a healthy subject ($) and an ascitic patient (#). The solid lines are the curves obtained by nonlinear least-squares regression analysis of the data. Results renal and systemic inulin clearances in both healthy and ascitic subjects. The correlation between the two parameters Representative examples of the plasma decay of inulin in was highly significant in both groups (r=0.96, P<0.001 healthy and ascitic subjects are shown in Figure 1. With the and r=0.98, P<0.001, respectively). Determination of renal exception of two ascitic patients, the best agreement between clearance as Ae (0,4 h)/auc (0,4 h) yielded values very theoretical curves and experimental data points was always similar and highly correlated to those calculated from total obtained using a tri-exponential equation. The pharmacokinetic urinary recovery (97.0 (12.4) and (18.6) ml min 1 for parameters characterizing inulin disposition are healthy and ascitic subjects, respectively; r>0.98 and shown in Table 1. The values of the volume of the central P<0.001 in either case). Systemic clearance estimates compartment and the steady-state volume of distribution in obtained by application of the logarithmic trapezoidal rule healthy volunteers were very similar to those observed in to six points (see Methods) were in close agreement with healthy subjects by Odeh et al. (3.90 and l 70 kg 1, those obtained from pharmacokinetic modelling of the respectively; [9]) and significantly lower than those observed decay curves (93.5 (9.2) and (19.6) ml min 1 for in ascitic patients. Very similar values were obtained for healthy and ascitic subjects, respectively) and also showed a 1998 Blackwell Science Ltd Br J Clin Pharmacol, 46,

4 R. Orlando et al. close correlation with renal clearance values (r=0.99, longer in patients with expanded extracellular fluid volume. P<0.001; r=0.97, P<0.001, respectively). The variability The method described in the present study requires no of the clearance estimates was similar with all four methods assumption regarding equilibrium and is therefore of more used. Intersubject coefficients of variation ranged from 10 general applicability. By this method, GFR can be accurately to 13% for healthy subjects and from 15 to 19% for and easily estimated also in oedematous patients from plasma ascitic patients. data alone over a relatively short period of time. When, as in routine clinical practice, the above described approach, Discussion requiring numerous blood samples for pharmacokinetic modelling, is not feasible, GFR can be estimated by a Our results regarding healthy subjects are very similar to simplified sampling protocol, without appreciable loss of those reported by Odeh et al. [9]. Like these authors, we precision. We have in fact shown that application of the found that inulin disposition kinetics are best described by a logarithmic trapezoidal rule to only six data points yields tri-exponential model. This underlines the inadequacy of the essentially equal results, with very similar coefficients of one- or two-exponential models often used to calculate inulin variation. clearance from plasma concentration data (reviewed in 1). In conclusion, this study has shown that determination of The values of V C and V SS found in this study are also in renal inulin clearance from the ratio of the amount excreted very close agreement with those obtained by Odeh et al. [9]. in the urine to the AUC over the corresponding period of On the contrary, significantly higher estimates were reported time, constitues a simpler and more precise clearance by Buclin et al. [7]: 7.4 and 13.4 l for V C and V SS, technique than the classic UV/P method, since it avoids respectively ( P<0.001 and P<0.01 compared to our errors connected with frequent urine collections. By this estimates). These discrepancies are most likely due to the fact method, we have demonstrated that renal and systemic that these authors used a bi-exponential equation to describe inulin clearances are virtually identical in both normal their data. We verified that using a bi-exponential instead of subjects and oedematous patients. Determination of systemic a tri-exponential model yields considerably lower values of inulin clearance by the presently described technique C(0) and, consequently, higher V C estimates. Atkinson and represents therefore a method of general applicability for coworkers [9, 12] interpreted the value of 3.90 l for V C as measuring GFR without the need for urine collection. indicating that the central compartment corresponds to the plasma space and proposed that transcapillary exchange is the rate-limiting step in inulin distribution. However, the This work was supported by a grant from MURST observed V (Ministero per l Università e la Ricerca Scientifica e C value is about 30% larger than the generally accepted value for plasma volume (3l 70 kg 1 ; [13]). This Tecnologica). The technical assistance of Mr P. Favero is suggests that part of the extracellular fluid is in rapid acknowledged. equilibrium with plasma. Consistent with this conclusion is the finding that the volume of the central compartment is about twice the plasma volume in ascitic patients. The value References of the steady-state volume of distribution obtained in this 1 Levinski NG, Lieberthal W. Clearance techniques. In study is in agreement with various previous estimates (see 6, Handbook of Physiology, section 8, volume 1, ed. Windhager 9 and references therein) and also in accordance with the EE. Oxford: Oxford University Press, 1992: tenet that the inulin space is rather smaller than the 2 Earle DP, Berliner RW. A simplified clinical procedure for extracellular fluid volume, averaging 13l 70 kg 1 [13]. measurement of glomerular filtration rate and renal plasma Our clearance measurements have shown that, contrary flow. Proc Soc Exp Biol Med 1946; 62: to the continuous i.v. infusion technique, the method based 3 Berger EY, Farber SJ, Earle DP. Comparison of the constant on the analysis of the area under the concentration-time infusion and urine collection techniques for the measurement of renal function. J Clin Invest 1948; 27: curve following bolus i.v. injection yields virtually identical 4 Hellerstein S, Berembom M, Alon U, Warady BA. The renal values of systemic and renal inulin clearances, in both clearance and infusion clearance of inulin are similar but not healthy subjects and patients with expanded extracellular identical. Kidney Int 1993; 44: fluid volume. In addition, the coefficients of variation of 5 Florijn KW, Barendregt JNM, Lentjes EGWM, et al. the two clearance parameters proved to be quite similar. Glomerular filtration rate measurement by single shot This contrasts with the results obtained by means of the injection of inulin. Kidney Int 1994; 45: UV/P method, which yielded renal clearance estimates 6 van Acker B, Koomen GCM, Arisz L. Drawbacks of the much more variable than those of total body clearance [5, 7]. constant-infusion technique for measurement of renal A major problem in the determination of systemic inulin function. Am J Physiol 1995; 268: F543 F552. clearance by the constant infusion technique is the attainment 7 Buclin T, Pechère-Bertschi A, Séchaud R, et al. Sinistrin of a true steady state. Van Acker et al. [6] showed that, 6 h clearance for determination of glomerular filtration rate: a reappraisal of various approaches using a new analytical after administration of a priming dose and onset of method. J Clin Pharmacol 1997; 37: continuous infusion, a steady-state concentration had still 8 Tucker GT. Measurement of the renal clearance of drugs. not been reached. In two patients they observed a continuous Br J Clin Pharmacol 1981; 12: increase in plasma inulin concentration throughout their 9 Odeh YK, Wang Z, Ruo TI, et al. Simultaneous analysis of 30 h study period. According to Hellerstein et al. [4], inulin and 15 N 2 -urea kinetics in humans. Clin Pharmacol Ther complete equilibration of inulin in the extracellular fluid is 1993; 53: a process that requires at least h. This process is still 10 Jung K, Klotzek S, Schulze BD. Refinements of assays for Blackwell Science Ltd Br J Clin Pharmacol, 46,

5 Short report low concentrations of inulin in serum. Nephron 1990; 54: multicompartmental models of drug distribution. Trends Pharmacol Sci 1991; 12: Wagner JG. Linear pharmacokinetic equations allowing direct 13 Lang F. The body compartments and dynamic of water and calculation of many needed parameters from the coefficients electrolytes. In Comprehensive Human Physiology. Eds Greger and exponents of polyexponential equations which have R, Windhorst U, Berlin: Springer Verlag 1996: been fitted to the data. J Pharmacokin Biopharm 1976; 4: ( Received 12 March 1998, 12 Atkinson AJ, Ruo TI, Frederiksen MC. Physiological basis of accepted 2 July 1998) 1998 Blackwell Science Ltd Br J Clin Pharmacol, 46,

PHA5128 Dose Optimization II Case Study I Spring 2013

PHA5128 Dose Optimization II Case Study I Spring 2013 Silsamicin is an investigational compound being evaluated for its antimicrobial effect. The route of administration for this drug is via intravenous bolus. Approximately 99.9% of this drug is eliminated

More information

Evaluation of the Cockroft Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients

Evaluation of the Cockroft Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients Original article Annals of Oncology 15: 291 295, 2004 DOI: 10.1093/annonc/mdh079 Evaluation of the Cockroft Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients G.

More information

Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation

Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation Nephrol Dial Transplant (2002) 17: 1909 1913 Original Article Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new () prediction equation

More information

BASIC PHARMACOKINETICS

BASIC PHARMACOKINETICS BASIC PHARMACOKINETICS MOHSEN A. HEDAYA CRC Press Taylor & Francis Croup Boca Raton London New York CRC Press is an imprint of the Taylor & Francis Group, an informa business Table of Contents Chapter

More information

COMPARTMENTAL ANALYSIS OF DRUG DISTRIBUTION Juan J.L. Lertora, M.D., Ph.D. Director Clinical Pharmacology Program September 23, 2010

COMPARTMENTAL ANALYSIS OF DRUG DISTRIBUTION Juan J.L. Lertora, M.D., Ph.D. Director Clinical Pharmacology Program September 23, 2010 COMPARTMENTAL ANALYSIS OF DRUG DISTRIBUTION Juan J.L. Lertora, M.D., Ph.D. Director Clinical Pharmacology Program September 23, 2010 Office of Clinical Research Training and Medical Education National

More information

PHA Second Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Second Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 5127 Second Exam Fall 2013 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Question/Points Set I 20 pts Set II 20 pts Set III 20 pts Set IV 20 pts Set

More information

Osnove farmakokinetike. Aleš Mrhar. Prirejeno po. A First Course in Pharmacokinetics and Biopharmaceutics by David Bourne,

Osnove farmakokinetike. Aleš Mrhar. Prirejeno po. A First Course in Pharmacokinetics and Biopharmaceutics by David Bourne, Osnove farmakokinetike Aleš Mrhar Prirejeno po A First Course in Pharmacokinetics and Biopharmaceutics by David Bourne, College of Pharmacy, University of Oklahoma Pharmacokinetics/Pharmacodynamics Pharmacodynamics

More information

Pharmacokinetics Overview

Pharmacokinetics Overview Pharmacokinetics Overview Disclaimer: This handout and the associated lectures are intended as a very superficial overview of pharmacokinetics. Summary of Important Terms and Concepts - Absorption, peak

More information

PHARMACOKINETICS OF DRUG ABSORPTION

PHARMACOKINETICS OF DRUG ABSORPTION Print Close Window Note: Large images and tables on this page may necessitate printing in landscape mode. Applied Biopharmaceutics & Pharmacokinetics > Chapter 7. Pharmacokinetics of Oral Absorption >

More information

General Principles of Pharmacology and Toxicology

General Principles of Pharmacology and Toxicology General Principles of Pharmacology and Toxicology Parisa Gazerani, Pharm D, PhD Assistant Professor Center for Sensory-Motor Interaction (SMI) Department of Health Science and Technology Aalborg University

More information

Pharmacokinetics of ibuprofen in man. I. Free and total

Pharmacokinetics of ibuprofen in man. I. Free and total Pharmacokinetics of ibuprofen in man. I. Free and total area/dose relationships Ibuprofen kinetics were studied in 15 subjects after four oral doses. Plasma levels of both total and free ibuprofen were

More information

ESTIMATION OF CREATININE CLEARANCE IN PATIENTS WITH UNSTABLE RENAL FUNCTION. Roger Jelliffe, USC School of Medicine

ESTIMATION OF CREATININE CLEARANCE IN PATIENTS WITH UNSTABLE RENAL FUNCTION. Roger Jelliffe, USC School of Medicine ESTIMATION OF CREATININE CLEARANCE IN PATIENTS WITH UNSTABLE RENAL FUNCTION. Roger Jelliffe, USC School of Medicine Measurement of creatinine clearance (CCr) has long been a problem in sick patients, largely

More information

Human Creatinine Urinary Detection Kit

Human Creatinine Urinary Detection Kit Human Creatinine Urinary CATALOG NO: IRAAKT2509 Detection Kit LOT NO: SAMPLE INTENDED USE The Urinary Creatinine kit is designed to quantitatively measure creatinine present in urine samples. BACKGROUND

More information

Title. Author(s)Hayakawa, Mineji; Fujita, Itaru; Iseki, Ken; Gando, CitationASAIO Journal, 55(3): Issue Date Doc URL. Rights.

Title. Author(s)Hayakawa, Mineji; Fujita, Itaru; Iseki, Ken; Gando, CitationASAIO Journal, 55(3): Issue Date Doc URL. Rights. Title The Administration of Ciprofloxacin During Continuou Author(s)Hayakawa, Mineji; Fujita, Itaru; Iseki, Ken; Gando, CitationASAIO Journal, 55(3): 243-245 Issue Date 2009-05 Doc URL http://hdl.handle.net/2115/43035

More information

Glomerular Filtration Rate. Hui Li, PhD, FCACB, DABCC

Glomerular Filtration Rate. Hui Li, PhD, FCACB, DABCC Glomerular Filtration Rate Hui Li, PhD, FCACB, DABCC Glomerular Filtration Rate (GFR): Amount of blood that is filtered per unit time through glomeruli. It is a measure of the function of kidneys. The

More information

Basic Concepts of TDM

Basic Concepts of TDM TDM Lecture 1 5 th stage What is TDM? Basic Concepts of TDM Therapeutic drug monitoring (TDM) is a branch of clinical pharmacology that specializes in the measurement of medication concentrations in blood.

More information

estimates were made of the normal rate of increase in plasma urea over periods in skin and in plasma, hypertonic sodium chloride solution was

estimates were made of the normal rate of increase in plasma urea over periods in skin and in plasma, hypertonic sodium chloride solution was 482 J. Physiol. (I95I) II5, 482-487 THE STTE OF BODY WTER IN THE CT BY M. GRCE EGGLETON From the Department of Physiology, University College, London (Received 5 July 1951) In the course of an investigation

More information

Basic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook with Computer Simulations

Basic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook with Computer Simulations Basic Pharmacokinetics and Pharmacodynamics: An Integrated Textbook with Computer Simulations Rosenbaum, Sara E. ISBN-13: 9780470569061 Table of Contents 1 Introduction to Pharmacokinetics and Pharmacodynamics.

More information

Biomath M263 Clinical Pharmacology

Biomath M263 Clinical Pharmacology Training Program in Translational Science Biomath M263 Clinical Pharmacology Spring 2013 www.ctsi.ucla.edu/education/training/webcasts Wednesdays 3 PM room 17-187 CHS 4/3/2013 Pharmacokinetics and Pharmacodynamics

More information

General Principles of Pharmacology and Toxicology

General Principles of Pharmacology and Toxicology General Principles of Pharmacology and Toxicology Parisa Gazerani, Pharm D, PhD Assistant Professor Center for Sensory-Motor Interaction (SMI) Department of Health Science and Technology Aalborg University

More information

(Received for publication May 8, 1948) The sustaining infusions were delivered by a pump at

(Received for publication May 8, 1948) The sustaining infusions were delivered by a pump at COMPARISON OF THE CONSTANT INFUSION AND URINE COLLECTION TECHNIQUES FOR THE MEASUREMENT OF RENAL FUNCTION BY EUGENE Y. BERGER, SAUL J. FARBER, AND DAVID P. EARLE, JR. WITH THE TECHNICAL ASSISTANCE OF ROSALYN

More information

Urinary inulin clearance for estimating glomerular

Urinary inulin clearance for estimating glomerular J Vet Intern Med 2013;27:17 21 A Single-Blood-Sample Method Using Inulin for Estimating Feline Glomerular Filtration Rate M. Katayama, J. Saito, R. Katayama, N. Yamagishi, I. Murayama, A. Miyano, and K.

More information

Flecainide pharmacokinetics in healthy volunteers: the influence of urinary ph

Flecainide pharmacokinetics in healthy volunteers: the influence of urinary ph Br. J. clin. Pharmac. (1985), 20, 333-338 Flecainide pharmacokinetics in healthy volunteers: the influence of urinary ph A. JOHNSTON, S. WARRNGTON' & P. TURNER Department of Clinical Pharmacology, St Bartholomew's

More information

One-Compartment Open Model: Intravenous Bolus Administration:

One-Compartment Open Model: Intravenous Bolus Administration: One-Compartment Open Model: Intravenous Bolus Administration: Introduction The most common and most desirable route of drug administration is orally by mouth using tablets, capsules, or oral solutions.

More information

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

PDF hosted at the Radboud Repository of the Radboud University Nijmegen PDF hosted at the Radboud Repository of the Radboud University Nijmegen This full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/14779

More information

Urea Nitrogen (BUN) detection Kit

Urea Nitrogen (BUN) detection Kit K-ASSAY KAMIYA BIOMEDICAL COMPANY KAMIYA BIOMEDICAL COMPANY Urea Nitrogen (BUN) detection Kit For the quantitative determination of urea nitrogen in saliva and TCM Cat. No. KT-747 For Research Use Only.

More information

Disposition of metronidazole and its effects on sulphasalazine

Disposition of metronidazole and its effects on sulphasalazine Br. J. clin. Pharmac. (1986), 21, 431-435 Disposition of metronidazole and its effects on sulphasalazine metabolism in patients with inflammatory bowel disease J. L. SHAFFER*,' A. KERSHAW2 & J. B. HOUSTON2

More information

Date... Name... Group... Urine sample (Tube No 2)

Date... Name... Group... Urine sample (Tube No 2) Date... Name... Group... Instructions for the practical lesson on biochemistry Topic: Non-protein nitrogen compounds Task 1: Estimation of creatinine in serum and urine 1. Trichloroacetic acid 1.22 mol/l

More information

COMPARTMENTAL ANALYSIS OF DRUG DISTRIBUTION

COMPARTMENTAL ANALYSIS OF DRUG DISTRIBUTION COMPARTMENTAL ANALYSIS OF DRUG DISTRIBUTION Juan J.L. Lertora, M.D., Ph.D. Director Clinical Pharmacology Program September 13, 2012 Office of Clinical Research Training and Medical Education National

More information

hold for the human kidney.2 Shannon and Smith (4) have rightfully stressed

hold for the human kidney.2 Shannon and Smith (4) have rightfully stressed THE RENAL EXCRETION OF INULIN AT LOW PLASMA CONCEN- TRATIONS OF THIS COMPOUND, AND ITS RELATIONSHIP TO THE GLOMERULAR FILTRATION RATE IN NORMAL, NEPHRITIC AND HYPERTENSIVE INDIVIDUALS' By BENJAMIN F. MILLER,

More information

BIOPHARMACEUTICS and CLINICAL PHARMACY

BIOPHARMACEUTICS and CLINICAL PHARMACY 11 years papers covered BIOPHARMACEUTICS and CLINICAL PHARMACY IV B.Pharm II Semester, Andhra University Topics: Absorption Distribution Protein binding Metabolism Excretion Bioavailability Drug Interactions

More information

Multiple IV Bolus Dose Administration

Multiple IV Bolus Dose Administration PHARMACOKINETICS Multiple IV Bolus Dose Administration ١ Multiple IV Bolus Dose Administration Objectives: 1) To understand drug accumulation after repeated dose administration 2) To recognize and use

More information

Pharmacokinetic Models Using Ordinary Differential Equations* DRUG DISTRIBUTION COMPARTMENTAL ANALYSIS OF DRUG DISTRIBUTION

Pharmacokinetic Models Using Ordinary Differential Equations* DRUG DISTRIBUTION COMPARTMENTAL ANALYSIS OF DRUG DISTRIBUTION COMPARTMENTAL ANALYSIS OF DRUG DISTRIBUTION Juan J.L. Lertora, M.D., Ph.D. Director Clinical Pharmacology Program September 10, 2015 Office of Clinical Research Training and Medical Education National

More information

The pharmacokinetics and safety of intravenous voriconazole a novel wide-spectrum antifungal agent

The pharmacokinetics and safety of intravenous voriconazole a novel wide-spectrum antifungal agent Blackwell Science, LtdOxford, UKBCPBritish Journal of Clinical Pharmacology1365-2125Blackwell Publishing 2356S129Original ArticlePharmacokinetics and safety of intravenous voriconazolel. Purkins et al.

More information

Renal Physiology. April, J. Mohan, PhD. Lecturer, Physiology Unit, Faculty of Medical Sciences, U.W.I., St Augustine.

Renal Physiology. April, J. Mohan, PhD. Lecturer, Physiology Unit, Faculty of Medical Sciences, U.W.I., St Augustine. Renal Physiology April, 2011 J. Mohan, PhD. Lecturer, Physiology Unit, Faculty of Medical Sciences, U.W.I., St Augustine. Office : Room 105, Physiology Unit. References: Koeppen B.E. & Stanton B.A. (2010).

More information

The estimation of kidney function with different formulas in overall population

The estimation of kidney function with different formulas in overall population 137 G E R I A T R I A 213; 7: 137-141 Akademia Medycyny ARTYKUŁ ORYGINALNY/ORIGINAL PAPER Otrzymano/Submitted: 28.8.213 Zaakceptowano/Accepted: 2.9.213 The estimation of kidney function with different

More information

The disposition of primidone in elderly patients

The disposition of primidone in elderly patients Br. J. clin. Pharmac. (1990), 30, 607-611 The disposition of primidone in elderly patients C. MARTINESl*, G. GATTIl, E. SASS02, S. CALZETIT2 & E. PERUCCA' 'Clinical Pharmacology Unit, Department of Internal

More information

PHA 5127 FINAL EXAM FALL On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA 5127 FINAL EXAM FALL On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 5127 FINAL EXAM FALL 1997 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Question Points 1. /14 pts 2. /10 pts 3. /8 pts 4 /8 pts 5. /12 pts 6. /8 pts

More information

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 5127 Second Exam Fall 2011 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Put all answers on the bubble sheet TOTAL /200 pts 1 Question Set I (True or

More information

Estimation of Glomerular Filtration Rate from Plasma Clearance of 51-Chromium Edetic Acid

Estimation of Glomerular Filtration Rate from Plasma Clearance of 51-Chromium Edetic Acid Archives of Disease in Childhood, 1972, 47, 613. Estimation of Glomerular Filtration Rate from Plasma Clearance of 51-Chromium Edetic Acid C. CHANTLER* and T. M. BARRATT From the Department of Immunology,

More information

Pharmacokinetics of propofol when given by intravenous

Pharmacokinetics of propofol when given by intravenous Br. J. clin. Pharmac. (199), 3, 144-148 Pharmacokinetics of propofol when given by intravenous infusion DENIS J. MORGAN', GWEN A. CAMPBELL2,* & DAVID P. CRANKSHAW2 'Victorian College of Pharmacy, 381 Royal

More information

Pharmacokinetic and pharmacodynamic interactions between phenprocoumon and atenolol or metoprolol

Pharmacokinetic and pharmacodynamic interactions between phenprocoumon and atenolol or metoprolol Br. J. clin. Pharmac. (1984), 17, 97S-12S Pharmacokinetic and pharmacodynamic interactions between phenprocoumon and atenolol or metoprolol H. SPAHN', W. KIRCH2,. MUTSCHLR',.. OHNHAUS2, N. R. KITFRINGHAM2,

More information

pharmacokinetics and tolerability of rizatriptan in healthy

pharmacokinetics and tolerability of rizatriptan in healthy Pharmacokinetics and tolerability of oral rizatriptan in healthy male and female volunteers Y. Lee, 1 J. A. Conroy, 2 M. E. Stepanavage, 3 C. M. Mendel, 2 G. Somers, 4 D. A. McLoughlin, 1 T. V. Olah, 1

More information

BIOL 2402 Renal Function

BIOL 2402 Renal Function BIOL 2402 Renal Function Dr. Chris Doumen Collin County Community College 1 Renal Clearance and GFR Refers to the volume of blood plasma from which a component is completely removed in one minute by all

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,900 116,000 120M Open access books available International authors and editors Downloads Our

More information

PHAR 7633 Chapter 20 Non Compartmental Analysis

PHAR 7633 Chapter 20 Non Compartmental Analysis Student Objectives for this Chapter PHAR 7633 Chapter 20 Non Compartmental Analysis To understand and use the non compartmental approach to parameter estimation be able to define, use, and calculate the

More information

PHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Final Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 5127 Final Exam Fall 2012 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Please transfer the answers onto the bubble sheet. The question number refers

More information

Use ideal body weight (IBW) unless actual body weight is less. Use the following equation to calculate IBW:

Use ideal body weight (IBW) unless actual body weight is less. Use the following equation to calculate IBW: Amikacin is a partially restricted (amber) antibiotic for the treatment of infections due to gentamicin resistant Gram negative bacilli or as advised by microbiology. As with other aminoglycosides, therapeutic

More information

Understand the physiological determinants of extent and rate of absorption

Understand the physiological determinants of extent and rate of absorption Absorption and Half-Life Nick Holford Dept Pharmacology & Clinical Pharmacology University of Auckland, New Zealand Objectives Understand the physiological determinants of extent and rate of absorption

More information

PHA 4120 Second Exam Key Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA 4120 Second Exam Key Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 4120 Second Exam Key Fall 1997 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Question Points 1. /10 ponts 2. /20 points 3. /10 points 4. /10 points

More information

ance of the sugar, until at plasma levels of 140 mgm. per cent the creatinine/sugar clearance ratio

ance of the sugar, until at plasma levels of 140 mgm. per cent the creatinine/sugar clearance ratio THE RENAL EXCRETION OF CREATININE IN MAN BY JAMES A. SHANNON 1 (From The Department of Physiology, New York University College of Medicine, New York City) In a previous paper the evidence on the excretion

More information

ab Sphingomyelin Assay Kit

ab Sphingomyelin Assay Kit ab133118 - Sphingomyelin Assay Kit Instructions for Use For the specific, sensitive and convenient method of quantifying Sphingomyelin in plasma or serum. This product is for research use only and is not

More information

Vancomycin Pharmacokinetics in Normal and Morbidly Obese Subjects

Vancomycin Pharmacokinetics in Normal and Morbidly Obese Subjects ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 1982, p. 575-58 66484/82/4575-6$2./ Vol. 21, No. 4 Vancomycin Pharmacokinetics in Normal and Morbidly Obese Subjects ROBERT A. BLOUIN,1 LARRY A. BAUER,3* DELWYN

More information

clamped. At 30- or 60-minute intervals urine specimens were collected and the bladder washed out with saline

clamped. At 30- or 60-minute intervals urine specimens were collected and the bladder washed out with saline Downloaded from http://www.jci.org on January 11, 218. https://doi.org/1.1172/jci11171 THE MECHANISM OF THE EXCRETION OF VITAMIN C BY THE HUMAN KIDNEY AT LOW AND NORMAL PLASMA LEVELS OF ASCORBIC ACID 1

More information

ACTIVE TRANSPORT OF SALICYLATE BY RAT JEJUNUM

ACTIVE TRANSPORT OF SALICYLATE BY RAT JEJUNUM Quarterly Journal of Experimental Physiology (1981) 66, 91-98 91 Printed in Great Britain ACTIVE TRANSPORT OF SALICYLATE BY RAT JEJUNUM R. B. FISHER University Laboratory of Physiology, Oxford (RECEIVED

More information

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

PHA Second Exam. Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment. PHA 5127 Second Exam Fall 2012 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Put all answers on the bubble sheet TOTAL /150 pts 1 Question Set I (True or

More information

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only. The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only. Please note that the results reported in any single trial may not reflect the overall

More information

PHA Final Exam Fall 2006

PHA Final Exam Fall 2006 PHA 5127 Final Exam Fall 2006 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Please transfer the answers onto the bubble sheet. The question number refers

More information

Saliva Versus Plasma Bioequivalence of Rusovastatin in Humans: Validation of Class III Drugs of the Salivary Excretion Classification System

Saliva Versus Plasma Bioequivalence of Rusovastatin in Humans: Validation of Class III Drugs of the Salivary Excretion Classification System Drugs R D (2015) 15:79 83 DOI 10.1007/s40268-015-0080-1 ORIGINAL RESEARCH ARTICLE Saliva Versus Plasma Bioequivalence of Rusovastatin in Humans: Validation of Class III Drugs of the Salivary Excretion

More information

Lack of pharmacokinetic interaction between the oral anti-influenza neuraminidase inhibitor prodrug oseltamivir and antacids

Lack of pharmacokinetic interaction between the oral anti-influenza neuraminidase inhibitor prodrug oseltamivir and antacids Blackwell Science, Ltdxford, UKBJCPBritish Journal of Clinical Pharmacology0306-5251Blackwell Science, 200254riginal Articleseltamivir and antacids lack of kinetic interactionp. Snell et al. Lack of pharmacokinetic

More information

Estimation of Serum Creatinine, Urine Creatinine and Creatinine Clearance. BCH472 [Practical] 1

Estimation of Serum Creatinine, Urine Creatinine and Creatinine Clearance. BCH472 [Practical] 1 Estimation of Serum Creatinine, Urine Creatinine and Creatinine Clearance BCH472 [Practical] 1 -Kidney functions: - The kidneys serve three essential functions: 1. They function as filters, removing metabolic

More information

Plasma Volume Expansion Resulting from Intravenous Glucose Tolerance Test

Plasma Volume Expansion Resulting from Intravenous Glucose Tolerance Test Plasma Volume Expansion Resulting from Intravenous Glucose Tolerance Test Robert Hahn and Thomas Nystrom Linköping University Post Print N.B.: When citing this work, cite the original article. This is

More information

DetectX. Urinary Creatinine Detection Kit. Catalog Number K002-H1. Sample Types Validated: Human, Monkey, Dog, Rat and Mouse Urine

DetectX. Urinary Creatinine Detection Kit. Catalog Number K002-H1. Sample Types Validated: Human, Monkey, Dog, Rat and Mouse Urine World s Only One Component Assay Simple & Easy to Use DetectX Urinary Creatinine Detection Kit Catalog Number K002-H1 Sample Types Validated: Human, Monkey, Dog, Rat and Mouse Urine Please read this insert

More information

Sebastião Rodrigues Ferreira-Filho, Camila Caetano Cardoso, Luiz Augusto Vieira de Castro, Ricardo Mendes Oliveira, and Renata Rodrigues Sá

Sebastião Rodrigues Ferreira-Filho, Camila Caetano Cardoso, Luiz Augusto Vieira de Castro, Ricardo Mendes Oliveira, and Renata Rodrigues Sá SAGE-Hindawi Access to Research International Nephrology Volume 211, Article ID 626178, 4 pages doi:1.461/211/626178 Research Article Comparison of Measured Creatinine Clearance and Clearances Estimated

More information

Blood Urea Nitrogen Enzymatic Kit Manual Catalog #:

Blood Urea Nitrogen Enzymatic Kit Manual Catalog #: Blood Urea Nitrogen Enzymatic Kit Manual Catalog #: 5602-01 TABLE OF CONTENTS GENERAL INFORMATION... 2 Product Description... 2 Procedure Overview... 2 Kit Contents, Storage and Shelf Life... 3 Required

More information

The pharmacokinetics and dose proportionality of cilazapril

The pharmacokinetics and dose proportionality of cilazapril Br. J. clin. Pharmac. (1989), 27, 199S-204S The pharmacokinetics and dose proportionality of cilazapril J. MASSARELLA, T. DEFEO, A. LIN, R. LIMJUCO & A. BROWN Departments of Drug Metabolism and Clinical

More information

Dr. M.Mothilal Assistant professor

Dr. M.Mothilal Assistant professor Dr. M.Mothilal Assistant professor Bioavailability is a measurement of the rate and extent of drug that reaches the systemic circulation from a drug product or a dosage form. There are two different types

More information

ab Creatinine Assay Kit (Colorimetric)

ab Creatinine Assay Kit (Colorimetric) ab204537 Creatinine Assay Kit (Colorimetric) Instructions for Use For the quantitative determination of Creatinine in urine samples. This product is for research use only and is not intended for diagnostic

More information

Modelling Acute Renal Failure using Blood and Breath Biomarkers in Rats

Modelling Acute Renal Failure using Blood and Breath Biomarkers in Rats Proceedings of the 7th IFAC Symposium on Modelling and Control in iomedical Systems, Aalborg, Denmark, August -, 9 ThT. Modelling Acute enal Failure using lood and reath iomarkers in ats Katherine T. Moorhead*,

More information

Evaluation of Renal Profile in Liver Cirrhosis Patients: A Clinical Study

Evaluation of Renal Profile in Liver Cirrhosis Patients: A Clinical Study Original article: Evaluation of Renal Profile in Liver Cirrhosis Patients: A Clinical Study Mukesh Agarwal Assistant Professor, Department of General Medicine, Teerthanker Mahaveer Medical College & Research

More information

Basic Pharmacokinetic Principles Stephen P. Roush, Pharm.D. Clinical Coordinator, Department of Pharmacy

Basic Pharmacokinetic Principles Stephen P. Roush, Pharm.D. Clinical Coordinator, Department of Pharmacy Basic Pharmacokinetic Principles Stephen P. Roush, Pharm.D. Clinical Coordinator, Department of Pharmacy I. General principles Applied pharmacokinetics - the process of using drug concentrations, pharmaco-kinetic

More information

BIPN100 F15 Human Physiology (Kristan) Problem Set #8 Solutions p. 1

BIPN100 F15 Human Physiology (Kristan) Problem Set #8 Solutions p. 1 BIPN100 F15 Human Physiology (Kristan) Problem Set #8 Solutions p. 1 1. a. Proximal tubule. b. Proximal tubule. c. Glomerular endothelial fenestrae, filtration slits between podocytes of Bowman's capsule.

More information

TDM. Measurement techniques used to determine cyclosporine level include:

TDM. Measurement techniques used to determine cyclosporine level include: TDM Lecture 15: Cyclosporine. Cyclosporine is a cyclic polypeptide medication with immunosuppressant effect. It has the ability to block the production of interleukin-2 and other cytokines by T-lymphocytes.

More information

Determination of Ethanol in Breath and Estimation of Blood Alcohol Concentration with Alcolmeter S-D2

Determination of Ethanol in Breath and Estimation of Blood Alcohol Concentration with Alcolmeter S-D2 Determination of Ethanol in Breath and Estimation of Blood Alcohol Concentration with Alcolmeter S-D2 A.W. Jones and KÄ. Jönsson Departments of Alcohol Toxicology and Internal Medicine, University Hospital,

More information

PROBLEM SET 7.1 FLUID VOLUMES, GLOMERULAR FILTRATION AND CLEARANCE

PROBLEM SET 7.1 FLUID VOLUMES, GLOMERULAR FILTRATION AND CLEARANCE PROBLEM SET 7.1 FLUID VOLUMES, GLOMERULAR FILTRATION AND CLEARANCE ANSWER KEY 1. The time course of decay of plasma [inulin] shown in Fig. 6.1.1 can be simultaneously used to determine the ECF volume and

More information

Renal Impairment From Dettli to Guideline: What can we learn?

Renal Impairment From Dettli to Guideline: What can we learn? Renal Impairment From Dettli to Guideline: What can we learn? SocraMetrics GmbH Mainzerhofplatz 14 99084 Erfurt phone: ++49-361-6020526 fax: ++49-361-6020525 e-mail: meinolf.wonnemann@socrametrics.de SocraMetrics

More information

Prothrombin (Human) ELISA Kit

Prothrombin (Human) ELISA Kit Prothrombin (Human) ELISA Kit Catalog Number KA0496 96 assays Version: 04 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 Principle of the Assay... 3 General

More information

PHA First Exam. Fall 2004

PHA First Exam. Fall 2004 PHA 5127 First Exam Fall 2004 On my honor, I have neither given nor received unauthorized aid in doing this assignment. Name Put all answers on the bubble sheet. If you need to comment or question a problem

More information

ADAM, a hands-on patient simulator for teaching principles of drug disposition and compartmental pharmacokinetics

ADAM, a hands-on patient simulator for teaching principles of drug disposition and compartmental pharmacokinetics British Journal of Clinical Pharmacology PHARMACOKINETICS Br J Clin Pharmacol (2017) 83 2426 2449 2426 ADAM, a hands-on patient simulator for teaching principles of drug disposition and compartmental pharmacokinetics

More information

TCP Transl Clin Pharmacol

TCP Transl Clin Pharmacol TCP 2015;23(1):26-30 http://dx.doi.org/10.12793/tcp.2015.23.1.26 Bioequivalence study of Donepezil hydrochloride in healthy Korean volunteers ORIGINAL ARTICLE Yewon Choi 1, Su-jin Rhee 1, In-Jin Jang 1,

More information

General renal pathophysiology

General renal pathophysiology General renal pathophysiology 1 Relationship between plasma solute concentration and its excretion by kidneys General scheme of a feedback regulation (ig 1) 1 Relationship between plasma solute concentration

More information

Noncompartmental Analysis (NCA) in PK, PK-based Design

Noncompartmental Analysis (NCA) in PK, PK-based Design Noncompartmental Analysis (NCA) in PK, PK-based Design Helmut Schütz BEBAC Consultancy Services for Bioequivalence and Bioavailability Studies 17 Vienna, Austria helmut.schuetz@bebac.at Bioequivalence

More information

C OBJECTIVES. Basic Pharmacokinetics LESSON. After completing Lesson 2, you should be able to:

C OBJECTIVES. Basic Pharmacokinetics LESSON. After completing Lesson 2, you should be able to: LESSON 2 Basic Pharmacokinetics C OBJECTIVES After completing Lesson 2, you should be able to: 1. Define the concept of apparent volume of distribution and use an appropriate mathematical equation to calculate

More information

From the Department of Pharmacology, University of Bristol (Received 5 April 1948)

From the Department of Pharmacology, University of Bristol (Received 5 April 1948) 197 J. Physiol. (I949) io8, I97-202 6I2.398.I45:6I2.46 EFFECT OF THE PROTEIN CONTENT OF THE DIET ON THE GLOMERULAR FILTRATION RATE OF YOUNG AND ADULT RATS BY S. E. DICKER From the Department of Pharmacology,

More information

Pharmacokinetics of drug infusions

Pharmacokinetics of drug infusions SA Hill MA PhD FRCA Key points The i.v. route provides the most predictable plasma concentrations. Pharmacodynamic effects of a drug are related to plasma concentration. Both plasma and effect compartments

More information

Bioequivalence Studies of Two Formulations of Famciclovir Tablets by HPLC Method

Bioequivalence Studies of Two Formulations of Famciclovir Tablets by HPLC Method Asian Journal of Chemistry Vol. 19, No. 6 (2007), 4245-4250 Bioequivalence Studies of Two Formulations of Famciclovir Tablets by HPLC Method K.V. SUBRAHMANYAM*, P. MOHANRAJ, P. SANDHYARANI, V.S. SARAVANAN

More information

Blood urea nitrogen (BUN) and serum creatinine concentrations

Blood urea nitrogen (BUN) and serum creatinine concentrations J Vet Intern Med 2001;15:368 373 Relationship between Plasma Iohexol Clearance and Urinary Exogenous Creatinine Clearance in Dogs Delmar R. Finco, W. Emmett Braselton, and Tanya A. Cooper The objective

More information

Renal Functions: Renal Functions: Renal Function: Produce Urine

Renal Functions: Renal Functions: Renal Function: Produce Urine Renal Functions: Excrete metabolic waste products Reabsorb vital nutrients Regulate osmolarity: Maintain ion balance Regulate extracellular fluid volume (and thus blood pressure) Renal Functions: Regulate

More information

Environmental Variability

Environmental Variability 1 Environmental Variability Body Size, Body Composition, Maturation and Organ Function Nick Holford Dept Pharmacology & Clinical Pharmacology University of Auckland 2 Objectives Understand the major sources

More information

Data Sheet. PCSK9[Biotinylated]-LDLR Binding Assay Kit Catalog # 72002

Data Sheet. PCSK9[Biotinylated]-LDLR Binding Assay Kit Catalog # 72002 Data Sheet PCSK9[Biotinylated]-LDLR Binding Assay Kit Catalog # 72002 DESCRIPTION: The PCSK9[Biotinylated]-LDLR Binding Assay Kit is designed for screening and profiling purposes. PCSK9 is known to function

More information

man of the effects of diabetes and of insulin on the maximum ability of the tubules to reabsorb glucose.

man of the effects of diabetes and of insulin on the maximum ability of the tubules to reabsorb glucose. EFFECT OF DIABETES AND INSULIN ON THE MAXIMUM CA- PACITY OF THE RENAL TUBULES TO REABSORB GLUCOSE t By SAUL J. FARBER, EUGENE Y. BERGER, AND DAVID P. EARLE (From the Department of Medicine, New York University

More information

Pharmacokinetics and allometric scaling of levormeloxifene, a selective oestrogen receptor modulator

Pharmacokinetics and allometric scaling of levormeloxifene, a selective oestrogen receptor modulator BIOPHARMACEUTICS & DRUG DISPOSITION Biopharm. Drug Dispos. 24: 121 129 (2003) Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/bdd.344 Pharmacokinetics and allometric scaling

More information

Renal Disease and PK/PD. Anjay Rastogi MD PhD Division of Nephrology

Renal Disease and PK/PD. Anjay Rastogi MD PhD Division of Nephrology Renal Disease and PK/PD Anjay Rastogi MD PhD Division of Nephrology Drugs and Kidneys Kidney is one of the major organ of drug elimination from the human body Renal disease and dialysis alters the pharmacokinetics

More information

A&P of the Urinary System

A&P of the Urinary System A&P of the Urinary System Week 44 1 Objectives Identify the organs of the urinary system, from a Identify the parts of the nephron (the functional unit List the characteristics of a normal urine specimen.

More information

GLUCOSE is the most important diffusible substance in the blood which

GLUCOSE is the most important diffusible substance in the blood which ON THE ACTION OF PHLORHIZIN ON THE KIDNEY. By E. B. MAYRS. (From the Department of Pharmacology, Edinburgh.) GLUCOSE is the most important diffusible substance in the blood which is completely held back

More information

RENAL SYSTEM 2 TRANSPORT PROPERTIES OF NEPHRON SEGMENTS Emma Jakoi, Ph.D.

RENAL SYSTEM 2 TRANSPORT PROPERTIES OF NEPHRON SEGMENTS Emma Jakoi, Ph.D. RENAL SYSTEM 2 TRANSPORT PROPERTIES OF NEPHRON SEGMENTS Emma Jakoi, Ph.D. Learning Objectives 1. Identify the region of the renal tubule in which reabsorption and secretion occur. 2. Describe the cellular

More information

Cutler, Power & Wilder, 1938; Hall & Langley, 1940), in the dog (Winkler &

Cutler, Power & Wilder, 1938; Hall & Langley, 1940), in the dog (Winkler & 8 J. Physiol. (I948) I07, 8-I3 6I2.46I.6 RENAL EXCRETION OF SODIUM AND POTASSIUM IN RATS BY S. E. DICKER (Beit Memorial Fellow) From the Department of Pharmacology, University of Bristol (Received 30 December

More information

Ch 17 Physiology of the Kidneys

Ch 17 Physiology of the Kidneys Ch 17 Physiology of the Kidneys Review Anatomy on your own SLOs List and describe the 4 major functions of the kidneys. List and explain the 4 processes of the urinary system. Diagram the filtration barriers

More information

BCH472 [Practical] 1

BCH472 [Practical] 1 BCH472 [Practical] 1 1. They function as filters, removing metabolic products and toxins from the blood and excreting them through the urine. 2. They regulate the body s fluid status, electrolyte balance,

More information

Nontraditional PharmD Program PRDO 7700 Pharmacokinetics Review Self-Assessment

Nontraditional PharmD Program PRDO 7700 Pharmacokinetics Review Self-Assessment Nontraditional PharmD Program PRDO 7700 Pharmacokinetics Review Self-Assessment Please consider the following questions. If you do not feel confident about the material being covered, then it is recommended

More information